Science ❯ Biotechnology

Protein Engineering

Artificial Intelligence AI in Biotech Antibody Technology Albumin Fusion Antibody Development Pharmaceuticals Artificial Proteins Immunology AI in Drug Discovery Therapeutic Technologies Therapeutics Monoclonal Antibodies

Sanofi Licenses Kali’s Tri-Specific Autoimmune Antibody KT501 in Deal Worth Up to $1.23 Billion

The move expands Sanofi’s push into T‑cell engagers for B‑cell diseases.

Microsoft-Led Study Exposes AI Biosecurity Gap as Patches Lift Detection to 97%

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

Australian AI Platform Designs Protein That Kills Drug-Resistant E. coli